Acyclovir Sodium Injection 10mL

SteriMax is pleased to announce the launch of Acyclovir Sodium for injection. To learn more visit the Acyclovir Sodium product page.

Ethacrynate Sodium for injection USP

SteriMax is pleased to announce the launch of Ethacrynate Sodium for injection. To learn more visit the Ethacrynate Sodium product page.

Ondansetron Injection USP

SteriMax is pleased to announce the launch of Ondansetron 8 mg / 4 mL (2 mg / mL). To learn more visit the Ondansetron product page.

Ondansetron Injection USP

SteriMax is pleased to announce the launch of Ondansetron 4 mg/ 2 mL (2 mg / mL). To learn more visit the Ondansetron product page.

Busulfan for Injection

SteriMax is pleased to announce the launch of Busulfan. To learn more visit the Busulfan product page.

SteriMax New Product Acquisition

SteriMax is pleased to announce the acquisition of the following products from Valeant Canada effective December 1st, 2017.

Furosemide for Injection

SteriMax is pleased to announce the launch of Furosemide for Injection. To learn more visit the Furosemide product page.

Bupivacaine Injection BP

SteriMax is pleased to announce the launch of Bupivacaine Injection BP. To learn more visit the Bupivacaine product page.

Diclofenac 1.5% w/w

SteriMax is pleased to announce the launch of Diclofenac 1.5% w/w. To learn more visit the Diclofenac product page.

SteriMax honored as the D.W Bole Award winner in the McKesson Annual Distinction 2015 Awards

Winners honored at the McKesson Award Ceremony in Montreal on September 9th, 2015. McKesson Canada’s annual Distinction event recognizes manufacturer excellence as well as exceptional collaboration – continuously working together towards improving the health of Canadians. This year, SteriMax was awarded the prestigious D.W. Bole Award, one of the six Distinction Awards presented to a manufacturer demonstrating excellence in their category. McKesson is a fortune 500 company and is...